期刊文献+

瓜蒌瞿麦丸合氯沙坦对糖尿病肾病早期尿微量白蛋白影响的研究 被引量:8

Study on Effect of Trichosanis Pills and Losartan on the Early Microalbuminuria of Diabetic Nephropathy
下载PDF
导出
摘要 目的研究瓜蒌瞿麦丸联合氯沙坦治疗糖尿病肾病早期微量白蛋白的临床效果如何。方法选取该院2016年5月—2017年5月诊断为糖尿病肾病患者共80例,将其随机分为研究组40例(应用瓜蒌瞿麦丸+氯沙坦治疗)及对照组40例(应用氯沙坦治疗),研究两组患者经过治疗前后的尿微量白蛋白的变化情况怎样。结果研究组治疗前后尿微量白蛋白(160.18±7.34)、(102.34±8.56)mg/L低于对照组(161.23±8.12)、(139.45±8.41)mg/L,差异有统计学意义(P<0.05)。结论瓜蒌瞿麦丸联合氯沙坦治疗方法可以显著的降低糖尿病肾病患者的微量白蛋白的排出量。 Objective To research the clinical effect of trichosanis pills and losartan on the early microalbuminuria of diabetic nephropathy. Methods 80 cases of patients with diabetic nephropathy diagnosed in our hospital from May2016 to May 2017 and randomly divided into two groups with 40 cases in each, the research group were treated with trichosanis pills and losartan, while the control group were treated with losartan, and the changes of microalbuminuria before and after treatment of the two groups were studied. Results The microalbuminuria before and after treatment in the research group were lower than that in the control group(160.18±7.34)mg/L,(102.34±8.56)mg/L vs(161.23±8.12)mg/L,(139.45±8.41)mg/L, with statistical significance(P〈0.05). Conclusion The trichosanis pills and losartan can obviously decrease the discharge of microalbuminuria of patients with diabetic nephropathy.
作者 赵宇 ZHAO Yu(Department of TCM,Qiqihar Hospital of TCM,Qiqihar,Heilongjiang Province,161000 China)
出处 《系统医学》 2018年第4期27-29,共3页 Systems Medicine
关键词 瓜蒌瞿麦丸 氯沙坦 糖尿病肾病 微量白蛋白 Triehosanis pills Losartan Diabetic nephropathy Mieroalbuminuria
  • 相关文献

参考文献10

二级参考文献71

  • 1王为平.肾炎康联合依那普利治疗老年糖尿病肾病的疗效[J].中国老年学杂志,2014,34(11):3026-3027. 被引量:9
  • 2孙宁玲,王鸿懿.高血压合并2型糖尿病患者的血压控制专家指导意见(2013版)[J].慢性病学杂志,2013(11):801-805. 被引量:14
  • 3陈文彬.诊断学[M] 第5版[M].北京:人民卫生出版社,2002.380.
  • 4张立.相约健康明天[J].糖尿病新世界,2003,5:3-3.
  • 5钱荣立.糖尿病正肆虐全球[J].糖尿病新天地,2000,11:4-4.
  • 6叶任高.内科学[M].北京:人民卫生出版社,2002.32.
  • 7任继学.任继学经验集[M].北京:人民卫生出版社,2000.70.
  • 8中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58.
  • 9Tamura K, Azushima K, Umemura S. Day-by-day home-measured blood pressure variability: another important factor in hypertension with diabetic nephropathy? [ J ]. Hypertens Res, 2011,34 ( 12 ) : 1249 - 1250.
  • 10Ito H, Mifune M ,Abe M, et al. Hypertension resistant to antihyper- tensive agents commonly occurs with the progression of diabetic ne- phropathy in Japanese patients with type 2 diabetes mellitus:a pro- spective observational study[ J]. BMC Nephrol,2012 ,13 :48.

共引文献80

同被引文献156

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部